<DOC>
	<DOCNO>NCT02449733</DOCNO>
	<brief_summary>The purpose study evaluate acceptability uptake combination package biomedical , behavioral community-level HIV prevention intervention service men sex men ( MSM ) South Africa .</brief_summary>
	<brief_title>Comprehensive HIV Prevention Package MSM Port Elizabeth</brief_title>
	<detailed_description>The objective Sibanye Health Project develop evaluate combination package biomedical , behavioral community-level HIV prevention intervention service men sex men ( MSM ) Africa . Experience implement prevention intervention preliminary data collect regard acceptability HIV prevention package use develop proposal design large efficacy trial test combination HIV prevention package MSM .</detailed_description>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>Male sex birth Anal sex another man past 12 month 18 year age old Resident study city , Port Elizabeth Able complete study instrument , without assistance , English , Xhosa Afrikaans Willing provide contact information Has phone Not male sex birth No selfreported anal sex man past 12 month Less 18 year age Not resident study city Plans move study city within year enrollment Not able complete study instruction , without assistance , English , Xhosa Afrikaans Not willing provide contact information Does phone Additional Inclusion Exclusion Criteria participant PrEP : PrEP Identified highrisk HIV provider meet one criterion : Have multiple partner Engage transactional sex , include sex worker Use abuse drug Drink alcohol heavily Had 1 episode STI last year Is HIVnegative partner discordant relationship , especially HIVpositive partner antiretroviral therapy ( ART ) Is nonmonogamous concordant relationship HIVnegative partner Is unable unwilling achieve consistent use male condoms No contraindication Emtricitabine/Tenofovir Disoproxil Fumarate ( FTC/TDF ) Calculated creatinine clearance least 60 mL/min Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &lt; 2 x upper limit normal ( ULN ) Hepatitis B surface antigen ( HBsAg ) negative Motivated follow PrEP prescribing guideline Willing adhere daily oral dose Willing attend PrEP maintenance visit every 3 month PrEP HIV positive Signs symptom suggestive acute HIV infection Have baseline creatinine clearance &lt; 60 ml/min Are unwilling follow PrEP prescribing guideline Are unwilling attend PrEP maintenance visit every 3 month Are know hypertensive diabetes Are hepatitis B susceptible ( test HBsAg HBsAb negative ) refuse take hepatitis B vaccine series Any contraindication take FTC/TDF Proteinuria 2+ great screen Glucosuria 2+ great screening Use antiretroviral ( ARV ) therapy ( e.g. , PEP PrEP ) 90 day prior study entry</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>voluntary counseling testing ( VCT )</keyword>
	<keyword>couple voluntary counsel testing ( CVCT )</keyword>
	<keyword>pre-exposure prophylaxis ( PrEP )</keyword>
	<keyword>homosexuality</keyword>
	<keyword>male</keyword>
	<keyword>South Africa</keyword>
</DOC>